NCT04515251 Ultrasound Evaluation of Superior Mesenteric Artery Measurements in a Healthy Pediatric Population
| NCT ID | NCT04515251 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ente Ospedaliero Cantonale, Bellinzona |
| Condition | Superior Mesenteric Artery Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 289 participants |
| Start Date | 2020-04-27 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 289 participants in total. It began in 2020-04-27 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multicenter, prospective, observational research project on children aged from 10 to 15 years old undergoing abdominal ultrasound examinations during routine clinical practice.
Eligibility Criteria
Inclusion Criteria: * Male and female children * Age ranging from10 to 15 years, included * Abdominal ultrasound examination to be performed for indications other than gastrointestinal evaluation * Signed Informed Consent Exclusion Criteria: * Presence of a disease that could distort the anatomy around the SMA (e.g., abdominal mass, lymphadenopathy, severe scoliosis, free abdominal fluid) * Oncologic patients at risk of neoplastic cachexia.
Contact & Investigator
Marirosa Cristallo Lacalamita, MD
PRINCIPAL INVESTIGATOR
Imaging Institute of Southern Switzerland
Frequently Asked Questions
Who can join the NCT04515251 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 15 Years, studying Superior Mesenteric Artery Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04515251 currently recruiting?
Yes, NCT04515251 is actively recruiting participants. Contact the research team at Marirosa.CristalloLacalamita@eoc.ch for enrollment information.
Where is the NCT04515251 trial being conducted?
This trial is being conducted at Bellinzona, Switzerland, Geneva, Switzerland.
Who is sponsoring the NCT04515251 clinical trial?
NCT04515251 is sponsored by Ente Ospedaliero Cantonale, Bellinzona. The principal investigator is Marirosa Cristallo Lacalamita, MD at Imaging Institute of Southern Switzerland. The trial plans to enroll 289 participants.